PATENT CLAIM ANALYSIS

Application Number: 15911713
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["506", "009000"]

Abstract:
Described are three-dimensional, engineered, biological breast tissues, adipose tissues, and tumor models, including breast cancer models.

Claim (Index 37):
A method of identifying a therapeutic agent for breast cancer in an individual, the method comprising:\n a. preparing a breast stromal bio-ink, the stromal bio-ink comprising a plurality of breast stromal cell types; b. preparing a breast tumor bio-ink, the tumor bio-ink comprising primary breast cancer cells from the individual; c. depositing the stromal bio-ink and the tumor bio-ink such that the tumor bio-ink is embedded in the stromal bio-ink and in contact with the stromal bio-ink on all sides; d. maturing the deposited bio-ink in a cell culture media to allow the cells to cohere to form a three-dimensional, engineered, breast cancer tumor model; e. applying a candidate therapeutic agent to the breast cancer tumor model; f. measuring viability of the breast cancer cells; and g. selecting a therapeutic agent for the individual based on the measured viability of the breast cancer cells; provided that the stromal bio-ink and the tumor bio-ink were deposited by bioprinting.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 90.0
- Lexical Diversity: 1.46667
- Patent Class: 506.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14678392', '14876659', '15259264', '14295226', '13841430']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.636290854307418
- 35 USC 102 Novelty (BERT): 0.6228168494932964
- Combined Prediction Score: 0.6349434538260059
- Mean Citation Score: 478.838696
- Max Citation Score: 736.5769700000003
- Similarity Product: 500.6519058535946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test